The Role of Oxidative Stress in Liver Cancer

A special issue of Antioxidants (ISSN 2076-3921). This special issue belongs to the section "Health Outcomes of Antioxidants and Oxidative Stress".

Deadline for manuscript submissions: closed (20 February 2024) | Viewed by 1537

Special Issue Editors

Unit of Experimental Medicine and Clinical Pathology, Department of Clinical & Biological Sciences, University of Torino, 10125 Torino, Italy
Interests: medicine; biochemistry; cellular and molecular biology

E-Mail Website
Guest Editor
Unit of Experimental Medicine and Clinical Pathology, Department of Clinical & Biological Sciences, University of Torino, 10125 Torino, Italy
Interests: cellular and molecular biology; chemistry and pharmaceutical technology

Special Issue Information

Dear Colleagues,

Oxidative stress (OS) is known to be associated with the development of hepatocellular carcinoma (HCC), which can arise from NAFLD (nonalcoholic fatty liver disease); recent evidence has shown that a significant proportion of NASH (nonalcoholic steatohepatitis) patients develop HCC in the absence of cirrhosis. However, the mechanisms between OS and HCC are still unclear, making their clarification of extreme interest.  In this scenario, the elucidation of the impact of OS on the development of liver carcinogenesis as well as on the prevention and treatment of liver cancer will be the focus of this Special Issue.

We invite you to submit your latest research findings or review articles to this Special Issue, including both in vitro and in vivo studies relating to the following topics: 

  1. OS and related molecules as promoters of HCC;
  2. OS as a modulator of chronic inflammation and fibrosis arising during HCC development;
  3. the peculiar role for OS in non-alcoholic fatty liver disease (NAFLD), its evolution to the inflammatory complication non-alcoholic steatohepatitis (NASH)  and  the final transition from NASH to HCC;
  4. OS as a target of therapy to reduce development and progression of HCC.

We look forward to your contribution.

Dr. Erica Novo
Dr. Claudia Bocca
Guest Editors

Manuscript Submission Information

Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.

Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Antioxidants is an international peer-reviewed open access monthly journal published by MDPI.

Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2900 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.

Keywords

  • oxidative stress
  • HCC
  • NAFLD
  • NASH
  • inflammation
  • liver fibrosis
  • cirrhosis

Published Papers (1 paper)

Order results
Result details
Select all
Export citation of selected articles as:

Review

19 pages, 935 KiB  
Review
Oxidative Stress and Redox-Dependent Pathways in Cholangiocarcinoma
by Alessandra Caligiuri, Matteo Becatti, Nunzia Porro, Serena Borghi, Fabio Marra, Mirella Pastore, Niccolò Taddei, Claudia Fiorillo and Alessandra Gentilini
Antioxidants 2024, 13(1), 28; https://doi.org/10.3390/antiox13010028 - 22 Dec 2023
Viewed by 968
Abstract
Cholangiocarcinoma (CCA) is a primary liver tumor that accounts for 2% of all cancer-related deaths worldwide yearly. It can arise from cholangiocytes of biliary tracts, peribiliary glands, and possibly from progenitor cells or even hepatocytes. CCA is characterized by high chemoresistance, aggressiveness, and [...] Read more.
Cholangiocarcinoma (CCA) is a primary liver tumor that accounts for 2% of all cancer-related deaths worldwide yearly. It can arise from cholangiocytes of biliary tracts, peribiliary glands, and possibly from progenitor cells or even hepatocytes. CCA is characterized by high chemoresistance, aggressiveness, and poor prognosis. Potentially curative surgical therapy is restricted to a small number of patients with early-stage disease (up to 35%). Accumulating evidence indicates that CCA is an oxidative stress-driven carcinoma resulting from chronic inflammation. Oxidative stress, due to enhanced reactive oxygen species (ROS) production and/or decreased antioxidants, has been recently suggested as a key factor in cholangiocyte oncogenesis through gene expression alterations and molecular damage. However, due to different experimental models and conditions, contradictory results regarding oxidative stress in cholangiocarcinoma have been reported. The role of ROS and antioxidants in cancer is controversial due to their context-dependent ability to stimulate tumorigenesis and support cancer cell proliferation or promote cell death. On these bases, the present narrative review is focused on illustrating the role of oxidative stress in cholangiocarcinoma and the main ROS-driven intracellular pathways. Heterogeneous data about antioxidant effects on cancer development are also discussed. Full article
(This article belongs to the Special Issue The Role of Oxidative Stress in Liver Cancer)
Show Figures

Figure 1

Back to TopTop